Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 17, 2026GeriatricsOpen Access

Aging in Schizophrenia: Clinical, Biological, and Psychosocial Perspectives

View Full Paper
Ask AI
Bookmark
Share

Authors

CMConstanza MorénAPAlonso Pérez‐ToribioEREnric Rubio-Contreras

Discussion

Loading...

Member takes

Overview

Integrative review uncovers evidence of accelerated biological, clinical, and psychosocial decline in older individuals with schizophrenia, highlighting the need for comprehensive care strategies.

Key Points

  • To synthesize current evidence on biological mechanisms, clinical manifestations, and psychosocial factors associated with aging and accelerated decline in schizophrenia.
  • Conducted an integrative review synthesizing clinical, biological, and psychosocial dimensions of the aging process in individuals with schizophrenia.
  • Evaluated intersecting contributions of cellular dysfunction, systemic comorbidities, polypharmacy, and psychosocial determinants of health.
  • Accelerated biological aging is driven by oxidative stress, mitochondrial dysfunction, chronic immune activation, and dysregulation of physiological stress-response systems.
  • Clinical presentation in older adults is dominated by high rates of cardiometabolic comorbidities, persistent cognitive impairment, and heightened functional dependency complicated by complex medication management.
  • Adverse psychosocial factors, including pervasive social isolation, stigma, and heavy caregiver burden, substantially worsen health trajectories and overall quality of life.

Cite This Study

Morén et al. (2026) studied this question.

synapsesocial.com/papers/6aabb68c5f706d05830e4fb3https://doi.org/10.3390/geriatrics11050133
View Full Paper
Ask AI
Bookmark
Share